Bank of America’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-378,016
| Closed | -$40.6M | – | 7053 |
|
|
2023
Q1 | $40.6M | Buy |
378,016
+183,559
| +94% | +$19.7M | ﹤0.01% | 1343 |
|
|
2022
Q4 | $21.4M | Buy |
194,457
+121,448
| +166% | +$13.4M | ﹤0.01% | 1677 |
|
|
2022
Q3 | $4.31M | Buy |
73,009
+58,394
| +400% | +$3.45M | ﹤0.01% | 2943 |
|
|
2022
Q2 | $413K | Buy |
14,615
+4,851
| +50% | +$137K | ﹤0.01% | 4862 |
|
|
2022
Q1 | $368K | Sell |
9,764
-8,647
| -47% | -$326K | ﹤0.01% | 5311 |
|
|
2021
Q4 | $728K | Buy |
18,411
+12,704
| +223% | +$502K | ﹤0.01% | 4825 |
|
|
2021
Q3 | $136K | Buy |
5,707
+1,566
| +38% | +$37.3K | ﹤0.01% | 5691 |
|
|
2021
Q2 | $102K | Buy |
4,141
+2,913
| +237% | +$71.8K | ﹤0.01% | 5729 |
|
|
2021
Q1 | $22K | Buy |
+1,228
| New | +$22K | ﹤0.01% | 6167 |
|